SARS-CoV-2

Showing NaN - NaN of 8

STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS

COVID-19, SARS-CoV-2 Trial in United States (VYD222, Normal saline)

Recruiting
  • COVID-19
  • SARS-CoV-2
  • Culver City, California
  • +15 more
Sep 8, 2023

Asymptomatic SARS-CoV-2 Detection in Children

Completed
  • Covid19
  • SARS-CoV-2
    • Birmingham, Alabama
    • +4 more
    Nov 1, 2022

    SARS-CoV-2 Trial in United States (CV2CoV (2 µg), CV2CoV (4 µg), CV2CoV (8 µg))

    Recruiting
    • SARS-CoV-2
    • CV2CoV (2 µg)
    • +5 more
    • La Mesa, California
    • +13 more
    Jul 21, 2022

    COVID-19, SARS-CoV-2 Trial in Chile, Peru, United States (AZD1222, Placebo)

    Active, not recruiting
    • COVID-19
    • SARS-CoV-2
    • AZD1222
    • Placebo
    • Phoenix, Arizona
    • +83 more
    Jul 13, 2022

    COVID-19, SARS-CoV-2 Trial in Puerto Rico, United States (Abatacept, Placebo)

    Terminated
    • COVID-19
    • SARS-CoV-2
    • Abatacept
    • Placebo
    • Hialeah, Florida
    • +9 more
    Jul 6, 2022

    Sars-CoV-2, Covid19 Trial in Brazil, United States (BLD-2660)

    Completed
    • Sars-CoV-2
    • Covid19
    • Irvine, California
    • +34 more
    Apr 1, 2022

    COVID, COVID-19, SARS-CoV-2 Trial in Worldwide (biological, other, drug)

    Completed
    • COVID
    • +3 more
    • Hyperimmune immunoglobulin to SARS-CoV-2 (hIVIG)
    • +2 more
    • Colorado Springs, Colorado
    • +38 more
    Mar 31, 2022

    COVID-19: Human Epidemiology and Response to SARS-CoV-2

    Completed
    • Coronavirus Disease 2019 (COVID-19)
    • SARS-CoV-2
    • Collection of Biological Samples
    • Symptom and Exposure Surveys
    • Aurora, Colorado
    • +19 more
    Feb 11, 2021